ABSTRACT
The composition and physical properties of the extracellular matrix (ECM) critically influence tumour cell behaviour, and ECM deposition and remodelling by stromal fibroblast populations is therefore pivotal for tumour progression. The molecular mechanisms by which stromal and tumour cell populations regulate ECM layering are poorly understood. Tumour-stroma interaction is critically dependent on cell-cell communication mediated by exosomes, small vesicles secreted by most cell types and generated within multivesicular bodies (MVBs). Here, we show that caveolin-1 (Cav1), an essential regulator of stromal remodelling and tumour cell fate, plays a central role in modulating both exosome biogenesis and exosomal protein cargo sorting through cholesterol-dependent mechanisms. Quantitative proteomics profiling revealed that a major share of Cav1-dependent exosomal cargoes are compsed of ECM proteins, one of the most important components being tenascin-C (TnC). Comparative functional assays demonstrated that Cav1 is required for fibroblast-derived exosomes to depose ECM and promote tumour cell invasiveness. Exosomes purified from Cav1WT cells, but not those from Cav1-null cells, were able to nucleate distant stromal niches in different organs in vivo. These findings suggest a key role for Cav1 as a cholesterol rheostat in MVBs, and seems to determine ECM deposition by eliciting ECM component sorting into specific exosome pools. These results, together with previous work, support a model in which Cav1 is a central regulatory hub for tumour-stroma interactions through a novel exosome-dependent ECM deposition mechanism.
INTRODUCTION
The tumour microenvironment is increasingly recognized as a key factor in multiple stages of disease progression, particularly local invasion and distant metastasis [1] [2] [3] . Cancer-associated fibroblasts (CAFs) are an important cell population in different carcinomas and constitute a major source of paracrine growth factors and ECM components for the tumour stroma 4, 5 .
However, understanding is limited on the molecular mechanisms that determine fibroblast ECM deposition. Recent studies confirm that ECM deposition ultimately depends on a functional core secretion machinery 6 , but further mechanistic characterization of ECM deposition is needed to fully characterize the broad impact of the ECM in health and disease and explore new therapeutic opportunities.
An important mechanism governing tumour-stroma interaction is exosomal cell-cell communication. Exosomes are secreted vesicles containing a variety of cargoes, and are generated from intraluminal vesicles (ILVs) in subpopulations of multivesicular bodies (MVBs), which are membrane-bound compartments intimately linked to the endosomal system [7] [8] [9] .
Secreted by most cell types, exosomes enable a given cell to modulate the behaviour of other cell populations through the transfer of effector or regulatory molecules over long (inter-organ) distances 10, 11 . Recent studies indicate that tumour-derived exosomes can promote premetastatic niche formation [12] [13] [14] . However, it remains unclear whether and how fibroblastderived exosomes might modulate these phenomena during tumour progression.
Exosomal cargo composition is heterogeneous and complex, containing a variety of proteins, small ligand peptides and regulatory nucleic acids 9 . It is clear that exosome composition, established by the donor cell, defines the modulatory effect on the receptor population, but little is known about how cargoes are selectively sorted into exosomes. Current evidence supports the co-existence of mechanisms dependent on the endosomal sorting complexes required for transport (ESCRT) machinery with ESCRT-independent mechanisms 15, 16 , likely reflecting the heterogeneity of MVBs and exosomes and their potential differential impact on health and disease.
Exosome biogenesis is also modulated by lipids through their ability to laterally segregate into specific membrane subdomains, which allows sorting platforms to be organized on the limiting membrane of MVBs 17 . Cholesterol is likely to be a highly relevant lipid in this context, given its significantly higher abundance in MVBs than in other endomembrane compartments 18 . Cholesterol is necessary for the formation of high-curvature membrane structures such as caveolae and synaptic vesicles, and a role in the intraluminal sorting of membranes destined for exosome secretion has been also proposed [19] [20] [21] . However, information remains scarce on the mechanisms modulating cholesterol levels in MVBs and their impact on exosome biology.
Contact sites between endosomes/MVBs and the ER membrane have recently been demonstrated as sites for the specific transfer of proteins and lipids (especially cholesterol).
Modulation of ER-MVB contacts depends on the interaction between different proteins, especially members of the ORP family (ORP1L and ORP5). Cholesterol accumulation in MVBs has been reported to reduce ER-MVB contacts 22 .
Endomembrane trafficking is regulated by caveolin-1 (Cav1), an essential scaffolding component of invaginated plasmalemal nanodomains (caveolae). Cav1 participates in several essential cell functions, including sensing and transduction of mechanical cues, endocytosis, spatiotemporal control of signal transduction, and cholesterol homeostasis. Moreover, we recently identified Cav1 as an integral component of mitochondria-associated ER membranes (MAMs), which are specialized ER regions that allow communication with mitochondria 23 . The pleiotropic functions of Cav1 support a pervasive yet context-dependent role in cancer progression and metastasis 24 . These diverse Cav1 functions include biomechanical 25 and compositional 26 remodelling of the ECM by CAFs to favour tumour invasion and metastasis, but the mechanisms through which Cav1 regulates ECM composition are unknown. Cav1 has been detected in exosomes 27 , but it has not been determined whether exosomal secretion is a specific means for Cav1-dependent ECM remodelling.
Here we demonstrate that Cav1 is a constitutive component of exosomes produced by several cell types, including primary CAFs. We show that ubiquitination-acceptor lysines at the N-terminal region of Cav1 are essential for its sorting into the MVB compartment.
Comparative proteomic and lipidomic studies showed that Cav1 modulates the sorting of exosome cargo and the segregation of exosome subpopulations through a cholesteroldependent mechanism. Intriguingly, exosomes derived from Cav1WT fibroblasts are significantly enriched in ECM components, including TnC, an important driver of tumour progression. Complementary in vitro approaches indicate that exosomal biogenesis and release are essential for fibroblast ECM deposition. Supporting Cav1-dependence of exosome competency for ECM deposition, exosomes derived from Cav1-null fibroblasts failed to promote protrusiveness, motility and invasiveness in a breast tumour cell line. Cav1-dependent remote ECM deposition by exosomes was recapitulated in vivo, suggesting an important role for stromal Cav1 in distant premetastatic niche formation in addition to its reported role in local ECM remodelling. We propose that Cav1 is a key regulatory hub promoting and coordinating primary and metastatic stromal environments by modulating both exosome biogenesis and specific exosomal cargo sorting. This regulation is exerted through the modulation of MVB membrane plasticity, which depends on cholesterol content and organization.
RESULTS

Internalized Cav1 redistributes to LE/MVB to its sorting in exosomes
Caveolin-1 internalization is tightly regulated [28] [29] [30] . Although endocytosed Cav1 has commonly been regarded as committed to degradation 31, 32 , alternative fates cannot be excluded 33 . To better define this process, we conducted confocal microscopy analysis of endogenous Cav1 trafficking dynamics in mouse embryonic fibroblasts (MEFs) and COS7 cells upon treatment with sodium orthovanadate, which induces Cav1 internalization by protecting Cav1 phosphorylation at tyrosine 14 30 . Orthovanadate exposure induced Cav1 phosphorylation, which correlated with increased colocalization with the late endosome (LE; immunostained with a monoclonal antibody to lyso-bis-phosphatidic acid (LBPA)) and multivesicular bodies (MVBs; immunodecorated for the CD63 marker) ( Fig. 1a and Supplementary Fig.1a ).
Similarly, a significant fraction of Cav1 relocalized to the LE/MVB compartment upon exposure of cells to EDTA, which induces Cav1 endocytosis by promoting cell detachment 34 , and in response to RNAi-mediated depletion of PTRF, an essencial caveolar coat component required for caveolae stabilization 35 ( Supplementary Fig. 1b and 1c) . Interestingly, PTRF depletion induced significant Cav1 phosphorylation ( Supplementary Fig. 1c ). High-resolution confocal microscopy confirmed the constitutive presence of Cav1 in the MVB lumen, colocalizing with the exosomal marker CD63 in normal conditions (Fig. 1b) . To confirm Cav1 internalization in LE and MVB lumens, we generated enlarged endosomes by overexpressing a constitutively active Rab5 mutant (Q79L) 36 . Discrete patches of Cav1 clearly localized to ILVs within MVBs (Fig. 1c) , delineated by accumulation of the specific exosomal markers Tsg101 and CD63 ( Supplementary Fig. 1d ). These observations demonstrate that MVBs are one of the destinies of endocytosed Cav1.
Phosphorylation and ubiquitination engage in an intricate interplay, with phosphorylation often serving as a trigger for subsequent ubiquitination of adjacent acceptor residues 37 .
Ubiquitination and deubiquitination appear to be important steps for protein sorting into ILVs within MVBs. To assess the importance of ubiquitination for Cav1 internalization into MVBs, we analyzed the subcellular distribution of Cav1 mutants in which arginine residues replace lysine residues that act as ubiquitination acceptors (Fig. 1d, upper panel) . All mutant forms nicely decorated the outer enlarged-Rab5 endosome membrane/MVB; however, mutation of the N-terminal lysine cluster (K5-57R and K5-176R mutants) abolished Cav1 sorting into ILVs (Fig. 1d) . Mutation of Cav1 N-terminal lysines hasbeen shown to impair Cav1 ubiquitination 38 . This result correlated with lower overall colocalization of these mutants with CD63
( Supplementary Fig. 1e ). In contrast, mutation of lysine residues in the carboxyl-terminal Cav1 region (K65-176R mutant) did not affect the ability of Cav1 proteins to localize in MVBs (Fig.   1d) . Interestingly, the overall phosphorylation level in these Cav1 mutants was not significantly altered ( Fig. 1e) , reinforcing the notion of a two-step mechanism driving Cav1 sorting into MVBs, with phosphorylation first eliciting Cav1 internalization towards the outer MVB membrane and ubiquitination then acting as a check-point for proper Cav1 sorting into the ILVs.
To test whether the ILV-localized Cav1 pool is effectively sorted into exosomes, we analyzed density gradient-purified exosomes from different cell lines (including tumour and fibroblast cells) by western blotting. Endogenous Cav1 mainly partitioned with Tsg101, confirming that exosomes can carry Cav1 (Fig. 1f) . Interestingly, Cav1 sorting to exosomes was favoured in PTRF-depleted MEFs (Supplmentary Figure 1f) , opposite to the impaired sorting of Cav1 mutants with disrupted N-terminal ubiquitination (Fig 1g) . Taken together, these data strongly suggest that a significant proportion of internalized Cav1 sorts to the MBV lumen in an ubiquitin-dependent manner, favouring its incorporation into exosomes. Furthermore, internalization of endogenous Cav1 into exosomes is a constitutive process in all Cav1-expressing cell lines tested.
Cav1 regulates exosomal biogenesis through modulation of MVB cholesterol content
A variety of mechanisms can modulate the composition and organization of membranes incorporated into MVBs, resulting in different ILV and exosome populations 9 . Because Cav1 is a key organizer of membrane architecture across cell compartments 24 , we explored whether Cav1 plays an active role in exosome biogenesis. Genetic ablation of Cav1 did not trigger a general, non-specific alteration of exosomal biogenesis; indeed, Cav1KO fibroblasts had even higher rates of exosome secretion, as determined by western blot of total purified exosomes from equal cell numbers (Fig. 2a upper panel and Figure 2b ), sedimentation across sucrose density gradients (Fig. 2a lower panel) , and physical characterization with Nanosight technology and transmission electron microscopy (TEM) (Fig. 2c and Fig. 2d ) 39 . However, Nanosight and TEM identified two differently sized exosome subpopulations in Cav1WT fibroblasts, whereas Cav1KO fibroblasts produced a homogeneous population containing the smaller exosomes ( Fig. 2c and 2d ), further suggesting a significant role for Cav1 in exosome biogenesis.
The ability of Cav1 to associate with specific lipids, particularly cholesterol, and to generate specialized membrane organization domains 24, 40 prompted us to study whether Cav1 promotes the exosome heterogeneity observed in preparations purified from Cav1WT MEFs by modulating cholesterol levels and membrane organization in MVBs. To explore this, Cav1WT and Cav1KO MEF cells were labelled with filipin, a well-known cholesterol marker.
While the number of LBPA-positive structures did not differ between Cav1WT and Cav1KO fibroblasts, MVB area and filipin intensity (a proxy for mean cholesterol content) were significantly higher in Cav1KO cells (Figure 2e ). This phenotype was recapitulated by siRNA depletion of Cav1 in Cav1WT cells (Supplementary Fig. 2a) . Interestingly, treatment of Cav1WT MEFs with U1866A, a specific promotor of cholesterol accumulation in the LE/MVB compartment 41 , increased exosome secretion while reducing exosome heterogeneity, thus mimmicking the phenotype of Cav1KO cells (Fig. 2f) .
A major share of MVB cholesterol is contained in ILVs 18 . We confirmed this cholesterol (Fig. 2g) , reflecting the increased high-ordered membrane content of Cav1KO-derived exosomes. Altered lipid composition as a major direct consequence of Cav1 deficiency in exosomes was further supported by mass spectrometry analysis of phosphatidic acid (PA), phosphatidylinositol (PI), and LBPA, which is essential for ILV budding from the MVB inner leaflet 42, 43 . Cav1WT-derived exosomes had significantly higher amounts than Cav1KO exosomes of these components (Supplementary fig. 2c ).
These results strongly indicate that Cav1 plays a key role in the modulation of exosome biogenesis by acting as a "cholesterol rheostat" in MVBs, thus conferring plasticity to this compartment and enabling the segregation of different exosome populations.
Cav1 promotes the sorting of specific ECM cargoes into exosomes
To determine whether Cav1-dependent heterogeneity in exosome size influences protein cargo composition, we analyzed proteins from Cav1WT and Cav1KO fibroblasts and their corresponding exosome preparations by isobaric labelling-based quantitative proteomics. This analysis identified a subproteome that is equally abundant in Cav1WT and Cav1KO wholecell lysates but whose components are differentially sorted to exosomes depending on Cav1 genotype ( Fig. 3a left panel) . At a change threshold of |Zq| > 1.5, 152 proteins from this subproteome were more abundant and 163 proteins were less abundant in Cav1KO exosomes than in Cav1WT exosomes. Interaction network and functional annotation enrichment analysis revealed that Cav1WT-derived exosomes were significantly enriched in ECM components (including TnC, fibronectin, nidogen, emilin, EDIL3 and heparan sulfate proteoglycans) and endosomal/endomembrane system components ( Table 1 ). Consistent with our data supporting an increased cholesterol content in Cav1KO MVBs, various annexin family members were substantially enriched in Cav1KO exosomes, despite the slightly decreased abundance of these proteins in Cav1KO whole-cell lysates (Fig. 3c) . Annexins are Ca 2+ -dependent proteins that bind cholesterol-rich membranes, providing lipid-clustering activity. Annexin enrichment in Cav1KO exosomes could may be a mechanism to sequester excess cholesterol in these exosomes.
The differential exosome sorting of selected gene products was validated by conventional western blot analysis (Fig. 3d) . A particularly marked difference was observed for TnC (Zq=3.02), an extracellular matrix protein involved in development, stem cell niche formation, and aggressive tumour metastasis [44] [45] [46] . TnC was prominently represented in Cav1WT-derived exosomes but virtually absent from Cav1KO exosomes (Supplementary Table 1 
Exosome biogenesis/secretion modulates ECM deposition
We next examined whether exosome-delivered ECM components can initiate de novo ECM deposition. Fluorescent immunolabelling and confocal microscopy revealed that Cav1KO fibroblast cultures deposit significantly less TnC fibre matrix in extracellular spaces than wild type cells, a result recapitulated by lentivirus-mediated knockdown in Cav1WT fibroblasts (Cav1KD) (Fig. 4a) . TnC fibre deposition was also reduced by treatment of Cav1WT cells with the cholesterol trafficiking inhibitor U18666A (Fig. 4b and 4c and Supplementary Fig. 3b ).
Reduced TnC deposition associated with Cav1 downregulation or genetic deletion was concomittant with intracelular TnC accumulation; in contrast, U18666A-treated wild-type cells showed less evident intracellular TnC retention, probably reflecting a much higher rate of TnC degradation in this condition (Fig. 4b) . Importantly, TnC was significantly less abundant in exosomes derived from Cav1KO and Cav1KD MEFs or U18666A-treated Cav1WT MEFs ( Fig.   4d and Supplementary Fig. 2f ), supporting a link between exosomes and TnC matrix deposition. To assess the contribution of exosomes to extracellular TnC fibre deposition, we treated Cav1WT fibroblasts with one of two available exosome secretion inhibitors: dimethylamiloride (dMA), an H+/Na+ and Na+/Ca2+ channel inhibitor, and GW4869, a neutral sphingomyelinase-2 (nSMAse2) inhibitor 36, 48 . Net exosome release by Cav1WT fibroblasts was reduced by nSMAse2 blockade, and to a lesser extent by H+/Na+ and Na+/Ca2+ channel blockade ( Supplementary Fig. 3a) , correlating with an impaired ability to deposit extracellular TnC fibres (Fig. 4e ). Both treatments also provoked the accumulation of dense intracellular TnC aggregates ( Supplementary Fig. 3c ). Importantly, the deposition of fibronectin (FN), another key ECM component underrepresented in Cav1KO exosomes ( Fig. 3b and Supplementary table 1), was also reduced by exposure to exosome secretion inhibitors, with GW4869 having a much stronger effect (Fig. 4f) . The general impact of exosome secretion on ECM deposition was also confirmed in primary cancer-associated fibroblasts (CAFs), a tumour stroma population with a key role in cancer progression. Exosome release by CAFs was largely inhibited by GW4869, whereas dmA had virtually no effect ( Supplementary Fig. 4a ).
Accordingly, TnC and FN deposition by CAFs was specifically affected by nSMAse2 blockade, whereas dMA had no effect ( Supplementary Fig. 4b and 4c) . Confocal analysis and quantitative ER stress assays showed that neither GW4869 nor dMA affected the function or knockdown of either pathway impaired TnC deposition; however, the phenotype was stronger upon ceramide synthesis disruption ( Fig. 4g and Supplementary Fig. 3h ). Similarly, the same knockdown conditions significantly reduced FN deposition ( Supplementary Fig. 3i ).
These data support a role of exosomes as a general ECM deposition mechanism, with ceramide-dependent exosome biogenesis as a major limiting step in this process.
TnC pools incorporated into exosomes have an intracellular origin
We next investigated the mechanisms underlying TnC incorporation into exosomes. To rule out an external orgin of exosome-incorporated TnC through endocytic trafficking, we developed an assay based on cell-derived matrices (CDMs). CDMs were generated by decellularization of ECMs synthesized in vitro by TnCWT or TnCKO MEFs. Immunostaining and microscopy analysis confirmed that TnCKO cells were specifically impaired for TnC deposition but not for deposition of other ECM components such as FN ( Fig. 5a and Supplementary Fig. 4f ). TnCKO or TnCWT cells were then seeded on each of these CDMs To further characterize TnC supply to exosomes, we conducted sucrose gradient ultracentrifugation analysis to separate MVBs from the endoplasmic reticulum (ER) and Golgi compartments (which fractionate together). In untreated Cav1WT cells, TnC co-sedimented with the MVB marker CD63 and the ER marker calreticulin (Fig. 5d) ; however, upon treatment with the exosome release inhibitor GW4869, TnC was largely excluded from CD63-positive fractions, a distribution shift recapitulated in Cav1KO-derived cell homogenates (Fig. 5d) .
Moreover, immunofluorescence analysis again revealed a major fraction of cellular TnC colocalizing with the ER marker in Cav1KO cells or GW4869-treated Cav1WT cells ( Fig. 5e and Supplementary Figure 4g ). Interestingly, this colocalization was significantly enhaced in the presence of the lysosomal inhibitor chloroquine. These results suggest that defective transfer of TnC from the ER to MVBs results in retention of TnC in the ER and its subsequent targeting for degradation, supporting the idea that lysosomal degradation is a mechanism of TnC removal when its sorting into exosomes is impaired. Degradation rate differences could explain the cell-cell variability in TnC accumulation in Cav1KO cells and in wild type cells treated with exosome inhibitor drugs and why severe disruption of exosome biogenesis and secretion does not entail a robust engagement of the unfolded protein response.
Together, these observations strongly support the view that the presence of TnC in exosomes reflects true regulated intracellular sorting of TnC into MVBs, likely through a mechanism involving ER-MVB contact sites, and that this exosomal TnC pool is sourced in the cell from de novo translation and not from endocytosed material.
Cav1-dependent exosome biogenesis directy drives ECM deposition and subsequent increase in tumour-cell invasiveness.
We next compared the ability of purified exosomes derived from either Cav1WT or Cav1KO
MEFs to deposit TnC on 2D cultures of the non-invasive breast cancer tumour cell line MDA-MB468, which naturally expresses negligible levels of Cav1 and TnC 49 Consistent with these EMT-like changes, MDA-MB468 cells concomitantly acquired an increased ability to migrate, as determined in wound healing studies and transwell cell migration assays (Supplementary Fig. 5c and 5d ). In contrast, exposure of MDA-MB468 cells to purified exosomes derived from Cav1KO fibroblasts induced no significant morphological changes ( Fig. 6a and 6b ). Interestingly, exosomes purified from MDA-MB231 tumour cells, which contain Cav1 but not TnC, also failed to induce an increase in MDA-MB468-cell protrusiveness and motility (Supplementary Fig. 5a and Supplementary Table 2), strongly indicating that exosomal TnC/ECM cargo, and not Cav1, is the direct driver of the phenotypic alterations.
The in vivo setting is more closely modelled by 3D culture methodologies 50 . We thus studied the ability of exosomes to deposit ECM on MDA-MB468 spheroids. Spheroids are scaffoldfree 3D assemblies in which cells self-organize ECM and engage in intercellular communication; spheroids have been validated as superior in vitro experimental proxies of live tissues for many applications 50, 51 . Consistent with the 2D culture experiments, Cav1WT-derived TnC-containing exosomes, but not exosomes derived from Cav1KO or Cav1KD fibroblasts (i.e. TnC-depleted), efficiently deposited fibrillar TnC structures within cell spheroids (Fig. 6c) . 3D-reconstruction of confocal optical sections across the whole spheroid volume demonstrated that TnC fibrils were preferentially located in the interstitial space, enveloped by the peripheral actin of the cell membranes (Supplementary Fig. 5e ). These experiments further support the view that exosomes from Cav1WT MEFs carry ECM components and are able to transfer these components to tumour cells for the deposition of new ECM.
To characterize Cav1-dependent, exosome-induced phenotypic changes in tumour cells, we monitored the boundary of MDA-MB468 spheroids over 72 h. Spheroids generated in the presence of Cav1WT-derived exosomes were seeded onto a plate and cells were allowed to migrate away from the spheroid. Cav1WT MEF-derived exosomes promoted significantly more migration than exosomes derived from Cav1KO MEFs (Fig. 6d) . To confirm the role of TnC in this process, we tested the effect of exosomes derived from TnCKO MEFs (Supplementary Fig. 5f and 5g ). TnCKO exosomes were poor stimulators of cell migration, supporting the view that the ability of Cav1WT MEF-derived exosomes to induce phenotypic changes in target tumour cells derives largely from Cav1-dependent sorting of specific ECM cargoes to exosomes.
We next examined whether exosome-induced tumour-cell protrusiveness and migration was associated with increased invasiveness through different substrates. Compared with exosomes derived from other sources, Cav1KO exosomes consistently exhibited a blunted ability to induce invasiveness in Matrigel invasion assays (Fig. 6e) or 3D collagen matrix invasion assays (Fig. 6f) , similar to the reduced invasion promoted by exosomes derived from TnCKO cells (Fig. 6g) ). These results further support the relevance of Cav1-and TnCdependent exosome-induced ECM deposition and phenotype alteration for tumour progression.
Cav1WT MEF-derived exosomes create TnC-rich niches in vivo
We next evaluated whether exosomes deposit TnC in vivo, surviving vascular dissemination over large (inter-organ) distances. We fluorescently labelled the membranes of exosomes purified from Cav1WT or Cav1KO fibroblasts and injected into the caudal veins of TnCKO mice every day for 1 week (Fig. 7a) . Histopathological analysis revealed specific exosome accumulation in liver, and to a lesser extent, in lung ( Fig. 7b and Supplementary Fig. 5h ).
However, associated TnC deposition was only consistently detectable in liver and lung of mice injected with Cav1WT-derived exosomes, contrasting the residual TnC staining in the organs of animals injected with Cav1KO exosomes or vehicle (PBS), despite Cav1KO derivedexosomes being able to reach to this organ with comparable efficiency. Intriguingly, TnC from Cav1WT exosomes tended to accumulate preferentially in liver sinusoids (Fig. 7b) , whereas in the lung TnC deposition was concentrated in areas surrounding mesenchymal cells (Supplementary Fig. 5h ). Moreover, Cav1WT-derived exosomes showed a moderate preference to accumulate in liver rather than lungs, whereas Cav1KO exosomes showed no such preference, despite efficient uptake across organs. These organ-specific peculiarities might indicate a Cav1-dependent role for exosomes in targeting a specific cell subpopulation for niche formation.
Our observations thus support a key role for Cav1 in exosome-dependent ECM deposition in vivo. TnC is a positive regulator of metastasis through the assembly of favourable distant microenvironments 52 , suggesting that Cav1 might specifically modulate cancer outcome through exosome-dependent stroma-tumour communication.
DISCUSSION
Exosomes have recently attracted attention due to their potential to provide a means by which tumour cells and associated stroma not only communicate locally, but also influence and transform distant locations or 'niches' and even modulate organismal responses systemically [12] [13] [14] . Despite the ubiquity of exosomes, the mechanisms underlying exosome biogenesis, cargo sorting, and function remain elusive. Here, we demonstrate the role of Cav1 as a modulator of exosome biogenesis through the regulation of cholesterol content in MVBs.
Cav1-dependent cholesterol modulation in this compartment permits the generation of exosomes with a higher heterogeneity, specifying exosome cargo subsets (mainly specific ECM proteins) and subsequent functional impacts. Our data demonstrate that the presence of Cav1 within exosomes is favoured by its endocytosis through specific phosphorylation at tyrosine 14. This phosphorylation step promotes Cav1 targeting to the MVB outer membrane, where a second mechanism is activated that requires the presence of ubiquitination-targeting N-terminal domain lysine residues; this second mechanism sorts Cav1 into ILVs for exosome generation. By virtue of its cholesterol-binding ability, Cav1 would act as a "cholesterol rheostat" in MVBs, thus increasing the plasticity of this compartment and enabling the segregation of different exosome populations, a phenomenon that as we have demonstrated can be perturbed by pharmacological treatments that directly affect intracellular cholesterol trafficking. The importance of cholesterol regulation in this compartment could also determine how exosome protein cargo is specified through modulation of contact between the ER and MVBs. (Fig. 7c, enlarged graph) .
Among the exosome-targeted ECM proteins identified, TnC is a key component involved in promoting exosome-dependent tumour invasion. TnC matrix deposition mediated by Cav1-expressing fibroblasts requires intact exosome biogenesis and secretion, as demonstrated by the effect of exosome inhibitors and siRNAs targeting exosome biogenesis-machinery components. Furthermore, our data support a model whereby the ER/Golgi compartment is a major direct supplier of TnC to these exosomes.
Exosomes secreted by Cav1WT fibroblasts have a dual effect, on the one hand stimulating protrusiveness and active migration of targeted tumour cells by inducing an EMT-like process, and on the other hand eliciting ECM deposition in areas surrounding the tumour. We demonstrate that this effect also takes place in vivo over large distances, suggesting that these mechanisms contribute to tumour-cell invasiveness and favour the establishment of distant metastatic foci by nucleating new ECM deposition (Fig. 7c ).
Cav1 is trafficked through several endomembrane systems, including late endosome/MVBs and lysosomes, suggesting the likely existence of several as yet unidentified caveolaeindependent Cav1 functions 24, 53 . Previous studies demonstrated that caveolae budding from the plasma membrane carry Cav1 to early endosomes, presumably allowing dynamic recycling and maintenance of these structures 54 . However, an alternative pathway has been described in which caveolae are disassembled and Cav1 is internalized and ubiquitinated, followed by accumulation at the internal membrane of late endosomes/MVBs 32, 35 .
Interestingly, Cav1 is also targeted to late endosomes by perturbations of lysosomal pH and changes in cholesterol content, with no changes in Cav1 degradation rate, raising the possibility of alternative fates for this Cav1 pool 33 . Our data demonstrate that a significant pool of endocytosed Cav1 is sorted into MVBs en route to exosomes (Fig. 1) , but we cannot rule out that other intracellular compartments such as the ER may also serve as a source of exosomal Cav1 ( Fig. 1 and supplementary Fig. 1 ).
Cav1 binds cholesterol with high affinity 40 and its ability to move between different compartments might contribute to the regulation of cholesterol fluxes and distribution within cells 55 . Our data demonstrate that Cav1 absence increases the level of free cholesterol in late endosomes/MVBs, suggesting that Cav1 is important for the modulation of membrane plasticity required for the generation of ILVs of varying size. ILV size heterogeneity would favour a specific and significant enrichment of extracellular matrix components in exosomes.
( Fig. 2 and Supplementary Fig. 2 and Fig.3) . Interestingly, among the identified Cav1-dependent exosomal cargoes, collagens are less abundant than other matrix proteins such as TnC, fibronectin, laminin, nidogen, and emilin. Collagen secretion requires specific assembly mechanisms operating through the COPII biosynthetic/secretory machinery 56 , and is thus unavailable to the exosome pathway. (Fig3, Fig. 4 and Supplementary Fig. 3 ).These pathways might be oppositely regulated by Cav1, since a negative correlation has been described between Cav1 expression and collagen deposition in chronologically-aged skin and during fibrosis 57, 58 .Our results strongly suggest that a previously overlooked critical function of Cav1 is ECM secretion via exosomes. Supporting our observation that exosomes can act as carriers of some extracellular matrix proteins, a recent study demonstrated exosomal secretion of FN through its binding to integrin α5β1; however, the function and underlying mechanism of this sorting were not determined. 59, 60 In constrast to Cav1WT-derived exosomes, the homogeneous exosome population produced by Cav1null cells has a strong tendency to aggregate (data not shown), which could be directly linked to the ability of annexins, significantly enriched in Cav1null exosomes, to favour cholerestol-enriched membrane aggregation 61 . Intriguingly, in the absence of Cav1, the main exosome protein components are related to DNA/RNA binding and nuclear functions, cargoes that may be favoured in conditions of metabolic stress (Fig. 3b ).
Our data demonstrate the importance of TnC secretion via exosomes and point to incorporation of TnC into ILVs through its sorting from the biosynthetic route to the MVB compartment, excluding the possibility of an extracellular origin through its internalization into the cell or by direct binding to exosomes once they are released ( Figure 5 ).
Recent work has revealed the presence of contact sites between MVBs and the ER 62, 63 , but the frequency, dynamics and physical architecture of these contacts are poorly understood.
Interestingly, our group has demonstrated the importance of Cav1 as a main component of a section of the smooth ER that forms close contacts with mitochondria 23 , suggesting that Cav1 may also modify ER-MVB contacts sites, thus modulating the incorporation of specific protein cargo into MVBs en route to exosomes.
The similar effects of TnCKO and Cav1KO exosomes (Fig. 6) suggest that the biological actions determined by secretion of Cav1WT-derived exosomes directly depend on exosome TnC content. Our results suggest that TnC has a dual effect of on tumour progression. Over short distances, fibroblast-derived TnC-rich exosomes are deposited in areas surrounding tumour cells. The presence of TnC at the tumour invasive front presumably induces an EMTlike process that drives tumour cell migration away from the bulk tumour mass, as evidenced in 2D and 3D assays (Fig. 6) . Similar results were obtained by direct addition of recombinant soluble TnC 64 . Together with this local effect, our data provide evidence for exosome-mediated TnC deposition over large distances to sites in lung and liver. Recent findings demonstrate that the microenvironment required for the formation of secondary metastatic sites is primed before the arrival of cancer cells, forming a "landing dock" for future metastatic growth 65 .
Establishment of a pre-metastatic niche is a multistep process involving the sequential activation of several cell types, as recently shown for metastasis of pancreatic cancer to liver 13 .
We propose that this orchestrated cascade is complemented by alternative mechanisms that directly promote pre-metastatic niche formation. Our results show that caudal vein injection of exosomes derived from Cav1WT fibroblasts can promote direct TnC-matrix deposition in distant organs (Fig. 7) .
In addition to the role of exosomes in tumour progression, altered extracellular vesicle secretion is also linked to several cholesterol-related diseases 66, 67 . This attracts particular attention in relation to atherosclerosis, where exosomes may be involved in monocyte and macrophage cholesterol metabolism, endothelial cell and platelet activation, and smooth muscle proliferation. Interestingly, Cav1 loss results in hypercholesterolemia but also protects against the development of aortic atheromas. Further investigation will be required to confirm whether modulation of exosomal Cav1 incorporation might provide an alternative way to modulate cholesterol levels as well as thre specific proatherogenic molecule cargo. The lysosomal storage disorder Niemann-Pick Type C (NPC) disease is also characterized by cholesterol accumulation in the endosomal-lysosomal system 68 . Whether exosomes can serve as diagnostic and therapeutic tools for NPC patients remains to be determined. Although the specific connections between cholesterol homeostasis and exosomes remain unclear, Cav1 appears to be a key player in this interaction.
Previous studies demonstrated high levels of Cav1-expressing exosomes in the plasma of melanoma patients 27 . We propose that relative levels of Cav1-expressing exosomes could be a valuable prognostic marker of metastasis and tumour malignancy as well as another cholesterol-related diseases. Our findings suggest new avenues for diagnosis, prevention, and therapeutic intervention based on specifically targeting Cav1-dependent roles in exosomal tumour-stroma communication. 
MATERIALS AND METHODS
Antibodies and reagents
Monoclonal anti-caveolin-1 (#3267) and anti-Alix (#2171) antibodies were from Cell Signaling Technology. Anti-LBPA was from Echelon (Z-SLBPA). Anti-CD63 (ab1318), anti-flotillin (ab13349), anti-periostin (ab14041), anti-Calreticulin (ab2907), anti-PTRF (ab48824) and anti-TSG101 (ab83) were from Abcam. Anti-GM130 (610823), anti-py14-caveolin-1 (611339) and anti-Cadherin (610181) were from BD transduction. Anti-tubulin (T-9026), anti-Fibronectin (F3648) and anti-tenascin (Clone Mtn-12, T3413) were from Sigma. Anti-Tenascin was also from Millipore (AB19011). Anti-nSMAse1 (sc-377135) and anti-nSMAse2 (sc-166637) were from Santa Cruz. Alexa fluor 488, 546 and 647-conjugated phalloidin were from Life Technologies. GW4869 (567715) was from Calbiochem and dimethylamiloride (dMA) (A4562) was from Sigma. Matrigel (354230) was from BD and Collagen I from rat tail (354249) was from Corning. Filipin was from Sigma (F4767).
Cell culture
Mouse embryonic fibroblasts derived from Cav1WT and Cav1KO littermate mice used throughout this study were kindly provided by Dr. Michael P. Lisanti. TnCWT and TnCKO MEFs were provided by our collaborator Dr. Gertraud Orend. PTRFKO cells were provided by Dr. Parton and were reconstituted with the retroviral expression vector pMIGR1. COS7 cells were from ATCC. MEFs and COS7 cells were cultured in Dulbecco´s modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum (FBS), 100 U/ml penicillin and 100 µg/ml streptomycin at 37ºC in a humidified 5% CO 2 -95% air incubator. The breast cancer associated fibroblast line CCD-1069S and the breast tumour cell line MDA-MB468 were cultured in DMEM/F-12 supplemented with 10% FBS, 100 U/ml penicillin and 100 µg/ml streptomycin. 
CCD-1069S fibroblasts
Isolation and characterization of exosomes released by fibroblasts
Exosomes were isolated from cultured fibroblasts grown in exosome-free culture medium. To remove detached cells, conditioned medium was collected and centrifuged at 300 g for 10 min at 4ºC. The supernatant was collected and centrifuged at 2000 g for 20 min at 4ºC. The supernatant was then centrifuged at 10000 g at 4ºC for 30 min to completely remove contaminating apoptotic bodies, microvesicles and cell debris. The clarified medium was then ultracentrifuged at 110,000 g at 4ºC for 70 min to pellet exosomes. The supernatant was carefully removed, and crude exosome-containing pellets were washed in ice-cold PBS. After a second round of ultracentrifugation, the resulting exosome pellets were resuspended in the desired volume of PBS.
For further purification, exosomes were ultracentrifuged on a discontinuous sucrose gradient including sucrose concentrations of 0.25M, 0.5M, 0.8M, 1.16M, 1.3M and 2M in 20 mM HEPES, pH 7.4. Exosome samples were laid on the bottom of the gradient in the 2M sucrose fraction, followed by centrifugation at 200,000 g for 18 h. Eleven individual 1 ml gradient fractions were manually collected. Fractions were diluted in PBS and centrifuged at 110,000 g for 1 h at 4ºC, and the resulting pellets were resuspended and analysed. Alternatively, an equal volume of cold acetone was added to each fraction and the proteins precipitated for 2 h at -20ºC. Protein pellets were collected by centrifugation at 16,000 g for 10 min and air dried to eliminate acetone traces. The protein precipitates were monitored by western blot for the expression of the exosomal markers Alix and Tsg101.
In all experiments, the exosomes used corresponded to the total exosome pellets resulting from the serial centrifugation steps; usually 10 6 exosome particles were added per cell.
Exosome uptake was performed in exosome-free medium.
Exosome concentrations and size distributions were determined by Nanoparticle Tracking Analysis (Nanosight).
Western blot analysis
Western blot samples were prepared with conventional 5X Laemmli sample buffer brought to 1X when mixed with the sample. The 5X Laemmli sample buffer is composed of 60 mM TrisHCl pH 6.8, 2% SDS, 10% glycerol, 5% β-mercaptoethanol, and 0.01% bromophenol blue.
Cell or exosome proteins were resolved by SDS-PAGE and transferred to nitrocellulose membranes. Blots were incubated for 2 h in PBS containing 5% skimmed milk and overnight with primary antibodies (typically diluted 1:1000). After incubation (2 h) with horseradish peroxidase-conjugated goat anti-rabbit or goat anti-mouse antibody, signal on washed blots was detected by enhanced chemiluminescence (GE Healthcare). Band intensities were quantified with Image J software.
Intracellular lysate analysis
To prepare lysates containing only proteins from the cell interior, plated cells were treated with trypsin to eliminate proteins in the extracellular space. Detached cells were washed with PBS and resuspended in loading buffer for western blot analysis. For total lysates comprising cell and ECM proteins, cells were scraped directly from the plate in loading buffer.
PKH67 labelling of exosomes
Purified exosomes were labelled with the green fluorescent dye PKH67 (Sigma MIDI67) according to the manufacturer´s protocol. After staining, unbound PKH67 was removed with columns from Thermo Fisher (4484449).
Electron microscopy
Exosomes were visualized by transmission electron microscopy (TEM) according to the method of Thery et al. 71 . The exosome suspension was fixed in 2% paraformaldehyde and transferred to formvar/carbon coated electron microscopy grids. After 20 minutes, grids were placed sample-face down for 2 minutes in a 100uL drop of PBS on a sheet of parafilm. Grids were then transferred to 1% glutaraldehyde for 5 minutes and then washed with distilled water.
Samples were contrasted in 2% uranyl acetate and examined by TEM.
Spheroid formation assay
After trypsinization, MDA-MB468 cells were resuspended in exosome-free DMEM, counted and adjusted to the desired concentration (usually 5X10 3 cells/ml). A 20 µL final volume was prepared with 5X methyl cellulose prepared in exosome-free medium, the MDA-MB468 cell suspension, and the desired number of exosomes (usually 1X10 6 particles). The mixture was carefully deposited in a drop on the inner surface of a 100 mm dish lid. The plate lid was placed on a plate containing 10 ml PBS to humidify the culture chamber. Under gravity, cells aggregated at the bottom of the hanging drop. After 24 hours, the resulting cell aggregates were lifted with a pipette. For 2D spheroid migration assays, the aggregates were seeded on a 96 well plate to monitor cell migration from the spheroid by phase-contrast time-lapse video microscopy. Alternatively, aggregates were seeded on collagen or matrigel gels as described below. In all assays, no additional exosomes were added to the medium apart from the exosomes used during spheroid generation.
Collagen embedding
High-density rat-tail type I collagen (Corning) was diluted to 2 mg/ml. This solution selfpolymerizes to form a gel after 20 to 30 min at 37 °C. Tumour cell spheroids were transferred to 25 µL unpolymerized collagen in the wells of a  slide angiogenesis plate (IBIDI). After 30 min, 40 µL medium was added over the top of the gel. Medium was replaced every 48 h.
Spheroids were imaged every 24 hours for the duration of the experiment. Spheroid diameter was measured from captured images with ImageJ.
For matrigel embedding assays, spheroids were transferred to a 25 µL 1:1 mix of matrigel and medium.
Wound closure assay
For wound healing assay, confluent monolayers were scraped with a 0.1-2 μl pipette tip in the presence of mitomycin C, and wound closure was monitored by capturing images at 10-min intervals.
Cell-derived matrix generation.
CDM generation was as described in Goetz et al., 2011.
Proteomic analysis
Lysates and exosomes derived from WT and Cav1 -/-MEFs were digested using the filter aided sample preparation (FASP) protocol 72 . Briefly, samples were dissolved in 50 mM Tris-HCl pH Trifluoroacetic acid (TFA) was added to a final concentration of 1% and the peptides were finally desalted onto C18 Oasis-HLB cartridges and dried-down for further analysis.
Multiplexed isobaric labelling.
For the quantitative analysis, tryptic peptides were dissolved in triethylammonium bicarbonate (TEAB) buffer, and the peptide concentration was determined by measuring amide bonds with the Direct Detect system. Equal amounts of each peptide sample were labelled using the 4-plex iTRAQ Reagents Multiplex Kit (Applied Biosystems). Briefly, each peptide solution was independently labelled at room temperature for 1 h with one iTRAQ reagent vial (mass tag 114, 115, 116 or 117) previously reconstituted with ethanol. After incubation at room temperature for 1 h, the reaction was stopped with diluted TFA and peptides were combined. Samples were concentrated in a Speed Vac, desalted onto C18 Oasis-HLB cartridges, and dried-down for mass spectrometry analysis.
Mass spectrometry. Digested peptides were loaded into the LC-MS/MS system for on-line desalting onto C18 cartridges and analysed by LC-MS/MS using a C-18 reversed phase nanocolumn (75 µm I.D. x 25 cm, 2 µm particle size, Acclaim PepMap RSLC, 100 C18; Thermo Fisher Scientific) in a continuous acetonitrile gradient consisting of 0-30% B for 240 min and 50-90% B for 3 min (A= 0.5% formic acid; B=90% acetonitrile, 0.5% formic acid). A flow rate of 200 nl/min was used to elute peptides from the RP nano-column to an emitter nanospray needle for real time ionization and peptide fragmentation in an Orbitrap QExactive mass spectrometer (Thermo Fisher). During the chromatography run, we examined an enhanced FT-resolution spectrum (resolution=70,000) followed by the HCD MS/MS spectra from the 20 most intense parent ions. Dynamic exclusion was set at 40 s. For increased proteome coverage, labelled samples were also fractioned by cation exchange chromatography (Oasis HLB-MCX columns); fractions were desalted and analysed using the same system and conditions described before. iTRAQ modifications as fixed modifications. Peptides were identified using the probability ratio method 73 , and false discovery rate (FDR) was calculated using inverted databases and the refined method 70 with an additional filtering for a precursor mass tolerance of 15 ppm 74 .
Identified peptides had a FDR equal to or lower than 1% FDR.
Proteins were quantified from reporter ion intensities and quantitative data analysed with QuiXoT, based on the WSPP statistical model 69, 70 . In this model, protein log2-ratios are standards were unavailable at the time of analysis, these species were quantified using 1-heptadecanoyl-2-arachidonoyl-3-phosphoglycerol and 1,2-dipentadecanoyl-sn-glycero-3-phosphocholine standards, respectively.
Subcellular fractionation
Intracellular compartments were separated by sucrose density gradient centrifugation. Cells were washed three times in 10 mM Tris-HCl pH 7.5, 0.5 mM MgCl 2 and then scraped and resuspended in 50 mM Tris-HCl pH 7.5, 0.25M sucrose. Cells were homogenized with 30 strokes using a Dounce homogenizer. The homonogenates were then centrifuged at 3000g
for 15 min at 4ºC. The supernatant was placed over a continuous sucrose gradient (2M at the bottom-0.25M at the top) and samples were separated at 100,000g for 18 hours in a SW40
rotor (Beckman) at 4ºC. After centrifugation, 1 ml fractions were collected from the tube, yielding a total of 12 fractions. Cold acetone (1 ml) was added to each tube and the homogeneous mixture was allowed to precipitate at -20ºC for 2 h. The samples were centrifuged at 16,000g at 4ºC and the protein pellets were allowed to dry for 2 h. The protein precipitates were then analysed by SDS-PAGE for proteins, including the ER marker calreticulin and the MVB marker CD63.
Preparation of detergent-resistant membrane fractions
DRMs from exosomes derived from Cav1WT and Cav1KO MEFs were purified as described in Navarro-Lerida et al. JCS (2002) with the Triton X-100 concentration reduced from 1% to 0.5%.
Transwell migration assay
The transwell migration assay was performed with Boyden chambers containing 8 µm poresize polycarbonate filter (Corning costar). Serum-free medium (300l) with or without exosomes was placed in the wells of a 24-well plate. The transwell inserts were placed in the wells and 5x10 4 MDA-MB468 cells in 200 l serum-free medium were added to the upper chamber. After incubation for 24 h, cells on the lower membrane surface were fixed and stained with crystal violet and counted under a microscope.
Animal model
All 
Immunohistochemical staining
Harvested tissues were fixed in 4% paraformaldehyde, processed through graded sucrose, 
Statistical analysis
Error bars depict SEM. 
